Assembly Biosciences is a biotechnology company dedicated to the development of innovative small molecule antiviral therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Led by an accomplished team of leaders in virologic drug development, Assembly Bio is committed to improving outcomes for patients struggling with the serious, chronic impacts of herpesvirus, hepatitis B virus (HBV) and hepatitis delta virus (HDV) infections. For more information, visit assemblybio.com.
Assembly is headquartered in South San Francisco.
|
|
|
51-200 employees
View all Assembly Biosciences, Inc. employees
|
|
Biotechnology
|
|
$10M–$50M
|
|
(415) 655-3000
|
|
331 Oyster Point Blvd, South San Francisco, California 94080, US
|
|
2014
|
|
Hepatitis B, Anti-Viral, Hbv Cure, Herpesvirus
|
Suzette Devito is the CEO of Assembly Biosciences, Inc.. To contact Suzette Devito email at [email protected] or [email protected].
The decision makers in Assembly Biosciences, Inc. are Alan Lewis, Dave Nicholls, Grace Wang, etc. Click to Find Assembly Biosciences, Inc. decision makers emails.
Assembly Biosciences, Inc. headquarters is located at 331 Oyster Point Blvd, South San Francisco, California 94080, US.
Assembly Biosciences, Inc. generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Assembly Biosciences, Inc. by calling (415) 655-3000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.